CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes Culprit versus multivessel coronary intervention in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials Myocardial Infarction in Young Women Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network) Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome

ConsensusVolume 72, Issue 18, October 2018

JOURNAL:J Am Coll Cardiol. Article Link

Fourth Universal Definition of Myocardial Infarction (2018)

Thygesen K, Alpert JS, Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Keywords: Cardiac procedural myocardial injury; Cardiac troponin; Expert Consensus Document; High sensitivity cardiac troponin; Myocardial infarction; Myocardial infarction with non-obstructive coronary arteries (MINOCA); Myocardial injury; Prior myocardial infarction; Re-infarction; Recurrent myocardial infarction; Silent myocardial infarction; Takotsubo syndrome; Type 1 MI; Type 2 MI; Type 3 MI; Type 4a MI; Type 4b MI; Type 4c MI; Type 5 MI

FULL TEXT PDF